Wells Fargo & Company Lantheus Holdings, Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 264,086 shares of LNTH stock, worth $24.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

264,086

Previous 236,743 11.55%

Holding current value

$24.1 Million

Previous $19 Million 52.48%

% of portfolio

0.01%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$77.7 - $123.62 $2.12 Million - $3.38 Million	27,343 Added 11.55%	264,086 $29 Million
Q2 2024 Aug 13, 2024	BUY	$58.87 - $83.05 $640,564 - $903,667	10,881 Added 4.82%	236,743 $19 Million
Q1 2024 May 10, 2024	SELL	$51.07 - $68.26 $10.5 Million - $14.1 Million	-205,852 Reduced 47.68%	225,862 $14.1 Million
Q4 2023 Feb 09, 2024	BUY	$55.6 - $77.89 $18.1 Million - $25.3 Million	325,349 Added 305.88%	431,714 $26.8 Million
Q3 2023 Nov 13, 2023	BUY	$60.27 - $90.75 $1.42 Million - $2.15 Million	23,643 Added 28.58%	106,365 $7.39 Million
Q2 2023 Aug 15, 2023	BUY	$82.41 - $99.65 $3.51 Million - $4.25 Million	42,604 Added 106.2%	82,722 $6.94 Million
Q1 2023 May 12, 2023	BUY	$47.76 - $82.86 $1 Million - $1.74 Million	20,993 Added 109.77%	40,118 $3.31 Million
Q4 2022 Feb 13, 2023	SELL	$48.76 - $77.67 $1.28 Million - $2.05 Million	-26,335 Reduced 57.93%	19,125 $974,000
Q3 2022 Nov 14, 2022	BUY	$61.42 - $86.29 $1.2 Million - $1.69 Million	19,598 Added 75.78%	45,460 $3.2 Million
Q2 2022 Aug 12, 2022	SELL	$55.54 - $72.65 $2.42 Million - $3.16 Million	-43,521 Reduced 62.73%	25,862 $1.71 Million
Q1 2022 May 16, 2022	SELL	$24.28 - $56.64 $329,698 - $769,114	-13,579 Reduced 16.37%	69,383 $3.84 Million
Q4 2021 Feb 14, 2022	BUY	$22.54 - $30.44 $363,006 - $490,236	16,105 Added 24.09%	82,962 $2.4 Million
Q3 2021 Nov 15, 2021	BUY	$24.23 - $28.59 $70,363 - $83,025	2,904 Added 4.54%	66,857 $1.72 Million
Q2 2021 Aug 16, 2021	BUY	$19.51 - $27.64 $552,698 - $783,013	28,329 Added 79.52%	63,953 $1.77 Million
Q1 2021 May 13, 2021	SELL	$13.77 - $21.66 $1.6 Million - $2.52 Million	-116,516 Reduced 76.58%	35,624 $762,000
Q4 2020 Feb 09, 2021	SELL	$10.75 - $14.91 $378,830 - $525,428	-35,240 Reduced 18.81%	152,140 $2.05 Million
Q3 2020 Nov 05, 2020	BUY	$11.98 - $16.34 $711,899 - $970,988	59,424 Added 46.44%	187,380 $2.37 Million
Q2 2020 Aug 13, 2020	SELL	$10.34 - $15.51 $131,504 - $197,256	-12,718 Reduced 9.04%	127,956 $1.83 Million
Q1 2020 May 14, 2020	BUY	$9.11 - $20.05 $1.28 Million - $2.82 Million	140,674 New	140,674 $1.8 Million

Others Institutions Holding LNTH

# of Institutions

540

Shares Held

68M

Call Options Held

679K

Put Options Held

423K

View Full List

About Lantheus Holdings, Inc.

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.28B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

More about LNTH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Lantheus Holdings, Inc. Transaction History